The Medicines Company   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Parsippany NJ United States (1996)
Status: Acquired by Novartis (2019)

Organization Overview

First Clinical Trial
1999
NCT00043940
First Marketed Drug
2000
bivalirudin (angiomax)
First NDA Approval
2000
bivalirudin (angiomax)
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | THE MEDICINES CO | The Medicines Company | The Medicines Company - Medical Director, Clinical Operations | The Medicines Company (Schweiz) GmbH